- Report
- October 2023
- 158 Pages
Latin America
From €3555EUR$3,959USD£3,027GBP
- Report
- April 2023
- 147 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- May 2023
- 147 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- December 2023
- 160 Pages
United States
From €2504EUR$2,789USD£2,132GBP
- Report
- November 2023
- 150 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- February 2024
- 150 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- February 2024
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- January 2022
- 100 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- January 2022
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2024
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- May 2024
- 130 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €8076EUR$8,995USD£6,878GBP
- Report
- June 2024
- 183 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- January 2024
- 250 Pages
Global
€4485EUR$4,995USD£3,819GBP
- Report
- September 2023
- 114 Pages
Global
From €2649EUR$2,950USD£2,256GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2649EUR$2,950USD£2,256GBP
- Report
- September 2023
- 89 Pages
From €2649EUR$2,950USD£2,256GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more